NuScale Power news

Despite trading below $10, the article explicitly states it is 'hard to describe NuScale as either a bargain or a value' and characterizes it as a 'high-risk bet' with no commercial sales yet. The company is money-losing, faces strict regulation, and has an unproven track record. Stock volatility is driven by sentiment rather than fundamentals, and the lack of firm contracts leaves shares 'languishing and drifting lower.'

While the E2 Centers represent a positive development in workforce training and technology adoption, the stock has declined 24.8% over six months and carries a Zacks Rank #3 (Hold) rating with an average brokerage recommendation of 2.68/5, indicating mixed market sentiment despite operational progress.

Stock down 45% year-to-date with recent weakness, but received offsetting positive catalysts including the Ratepayer Protection Act and EU support for SMRs. Stock rose ~10% on recent positive news, suggesting stabilization despite near-term headwinds.

The company achieved a significant engineering milestone with successful fabrication of critical safety components, demonstrating progress toward commercial deployment. However, this is tempered by the fact that operational deployment is still years away (2030s) and the company faces execution risks and regulatory hurdles.

Government support from the European Investment Bank's planned SMR investment pipeline should help NuScale convert its customer pipeline into revenue-generating projects and provide proof points for SMR technology viability, though this is characterized as a long-term tailwind.

The article highlights significant concerns about NuScale's business model, citing research showing operating costs ($93/MWh) far exceeding market electricity prices ($42-45/MWh). The company has no commercial reactors in operation, and a previous major project was canceled after costs nearly doubled. These factors create substantial uncertainty about the company's ability to achieve profitability.

While the company has promising SMR technology and is progressing toward a potentially game-changing TVA deal, the agreement remains non-binding with no revenue generated yet. The 75% stock decline, minimal Q2 revenue ($75,000), recent analyst downgrade, and CFO share sales indicate significant uncertainty and investor skepticism despite management optimism.

Stock has declined 75% over 12 months due to rising uncertainty about customer commitments. The company's largest customer pulled out in 2023 due to rising costs. The critical catalyst—securing a binding financial agreement by end of 2026—remains uncertain, and failure to achieve it could collapse the entire investment thesis. Industry history shows more SMR projects have failed than succeeded.

Most advanced of the three with approved reactor design, confirmed customer interest from RoPower, and manufacturing capabilities being developed. Closest to securing first commercial deal, giving it competitive advantage over peers.

The analyst predicts significant upside potential (474% gain to $57.42 by 2030) based on expected commercial progress and a major TVA deployment project. Despite acknowledging the stock's 83% decline and risks, the author expresses confidence in future demand for nuclear power and the company's path to profitability through binding agreements.

Lower analyst price target (only 30% upside), exposed to supply chain friction and customer cancellations, relies on slower municipal utility sales cycles rather than direct tech partnerships, weaker financial position ($766.5M cash vs. $824.4M debt), and less favorable business model compared to Oklo.

While the company has regulatory approval and benefits from AI/data center demand tailwinds, it faces significant headwinds: 99% revenue collapse, ongoing cash burn, years until first reactor deployment, and unproven commercial execution. Stock gains appear speculative rather than fundamentally justified. The company is betting on future PPAs to justify current valuation and continued cash burn.

While the article highlights NuScale's hydrogen production potential and technological advantages, the stock has lost over 20% in the past six months and carries a Zacks Rank #3 (Hold) rating with an average brokerage recommendation of 2.58/5, indicating mixed market sentiment despite promising fundamentals.

Bank of America analyst maintains a buy rating with 24% upside potential. The company has strengthened its balance sheet with $1.9B in cash, addressing funding concerns. The primary catalyst—securing a PPA for the TVA project by end of 2026—could validate the technology and unlock significant value. Wall Street consensus also supports a $12 price target.

Company is leveraging AI to improve operational efficiency with 80% reduction in information verification time, maintains first-mover advantage with NRC approval, and is pursuing major contracts. However, sentiment is tempered by early-stage status and lack of major hyperscaler deals.

While the stock has declined significantly and the company has no operating reactors or confirmed customers, it possesses the only NRC-approved SMR design in the U.S. and is pursuing a potentially massive TVA project. The author acknowledges improved positioning but emphasizes the investment remains highly speculative with uncertain revenue generation and substantial required milestone payments before commercialization.

While the company demonstrated operational progress in supply chain expansion and commercial readiness with strong liquidity ($1.89B), the massive 98.8% revenue decline and continued losses are concerning. Upward estimate revisions and advancing partnerships provide some optimism, but the Zacks Rank #3 (Hold) rating and poor VGM scores (all F grades) suggest limited near-term upside potential.

While NuScale operates in the growing SMR market with potential from AI energy demand, the article positions it as less attractive than Oklo. As primarily an equipment and technology provider rather than vertically integrated, NuScale faces lower revenue opportunities and lacks major customer partnerships like Oklo's Meta deal, though it still benefits from sector tailwinds.

Successfully fabricated specialized safety components and demonstrated progress toward commercialization of its NRC-approved SMR technology. The achievement advances manufacturing capabilities and supply chain development needed for commercial deployment.

Similar challenges to Oklo with added concern that the company has yet to commercialize its SMR designs. Public opposition to data centers and natural gas alternatives threaten the premium pricing advantage of SMRs. Stock down 4.62% on the day.

While the article highlights a potential positive catalyst (PPA signing), significant uncertainties remain. The company has never commercialized technology, experienced major project failures, operates at negative cash flow, and stock has fallen 40-75%. The potential PPA is speculative and not yet signed.

The article highlights structural disadvantages in NuScale's deal: it doesn't own the reactors, faces capped pricing on modules, has no discretion over ENTRA1's purchasing decisions, is making large payments to its partner before receiving revenue, and has minimal current revenue ($75,000 in Q2 2026) while burning cash. The analyst explicitly recommends staying on the sidelines.

Stock down ~41% in 2026. Similar challenges to Oklo including no commercialized systems, distant cash flows (2030-2040), quarterly losses, shareholder dilution concerns, and overvaluation at $10B market cap in January despite long development timeline.

Increased reliance on natural gas as a bridge fuel could delay SMR adoption by AI companies seeking lower-cost, lower-risk solutions. The company is unprofitable with limited real-world traction (only 2 SMRs in commercial operation globally), and delayed cash flows could increase shareholder dilution and long-term viability concerns.

Author views NuScale as too speculative and long-term with minimal current revenue ($75,000 in Q2), unproven commercial viability, and significant execution risk despite promising technology. Stock has crashed 80% from peak.

While NuScale has a first-mover advantage with NRC approval and promising partnerships (TVA, ENTRA1, Curio), the company faces significant timing challenges. Its technology won't be operational until the early 2030s, making it unable to address immediate AI data center power needs. The article characterizes it as 'highly speculative' and a 'long-term prospect,' indicating both opportunity and substantial execution risk.

While earnings were disappointing with 99% revenue decline and missed estimates, the article emphasizes that minimal current results are expected and irrelevant to long-term potential. The stock's flat reaction post-earnings and the potential PPA catalyst by end of 2026 suggest cautious optimism for future growth, warranting a neutral stance rather than negative despite poor current metrics.

Positioned in a high-growth market with strong tailwinds from AI/data center demand and nuclear energy adoption. A signed PPA with TVA by end of 2026 could be a major catalyst for revenue generation and stock appreciation. However, sentiment is tempered by execution risks and historical project failures.

While Q2 results show severe revenue decline, the stock gained on positive forward-looking indicators including NRC approval, established supply chain partnerships, and manufacturing readiness. However, the lack of binding customer contracts and actual deployment remains a significant concern, warranting a neutral stance rather than positive.

Stock has plunged 80% over 12 months due to cash burn, lack of near-term catalysts, expensive valuation at 55x sales, and no reactor deployment expected until early 2030s. Company is not yet profitable and relies on FEED studies and consulting work for revenue.

While the 6 GW deployment program represents a significant milestone as NuScale's first large-scale commercial validation opportunity, the non-binding nature of the agreement, substantial upfront payments ($495M already paid, potential $1.15B more), and lack of guaranteed revenue make this a mixed development. The deal is promising but too uncertain to warrant positive sentiment without binding commitments.

The article presents a bullish long-term thesis, highlighting NuScale's approved SMR technology, two major deployment projects, and positioning to capitalize on growing electricity demand. The author predicts significant wealth creation potential by 2036 for patient investors, despite acknowledging near-term execution risks.

Despite NRC approval and initial investor enthusiasm, NuScale has fallen significantly out of favor (down 84% in the past year). Commercial applications remain in negotiation stage with commercialization years away. The $2.6B market cap requires investors to pay for potential growth today, while facing similar cash burn and dilution risks as Oklo.

Stock surged 12% on optimistic investor sentiment regarding data center development and potential demand for SMR technology to power AI computing facilities. However, the article notes substantial investment risk remains.

Despite having regulatory approval and major contracts, the company faces severe near-term challenges: negative free cash flow of $750 million, negligible revenue, delayed project timelines (no revenue until 2030), and inability to capitalize on the current AI data center boom. The stock has declined 38% year-to-date and is expected to face further downside pressure.

Notably excluded from Project Prometheus for the second time, with no DoE support since 2019. Continued exclusion signals lack of government backing compared to competing nuclear startups.

Stock fell 29% in H1 2026 and 38% YTD due to delayed commercialization (first module not until 2031), massive operating losses ($690M in Q4 2025, $44M in Q1 2026), plummeting revenue, significant milestone payments without guaranteed returns, and loss of confidence from major shareholder Fluor's complete exit.

Company has first-mover advantage with NRC-approved SMR technology and secured Romanian project, but faces significant execution risks, long timelines (operations starting 2033), and competitive threats from DOE's Reactor Pilot Program accelerating competitor technologies.

While NuScale holds a unique regulatory approval and benefits from nuclear energy tailwinds, its competitive advantage has been significantly eroded by accelerated regulatory timelines for competitors. The company has only one secured project (Romania) and lacks firm commitments beyond that, making it a high-risk investment despite the attractive valuation.

NuScale is positioned as the superior solution with approved SMR design in the U.S., shorter construction periods, lower land requirements, and ability to co-locate with data centers. It's the only pure-play SMR stock available, making it a unique investment opportunity in a high-demand market.

Money-losing startup with unproven small modular reactor technology; much work remains before becoming significant industry factor; subject to sentiment swings and funding uncertainty

Listed as a key market player in the growing SMR sector with significant market opportunities ahead as the industry expands.

Mentioned as a competitor developing small modular reactor technology, but no specific performance data or sentiment indicators provided in the article.

NuScale is mentioned as a competitor in the SMR space but receives minimal coverage in the article. It is referenced only in comparison rankings without specific performance data or analysis provided.

Advancing engineering work on VOYGR plant configuration with utility partners targeting late-decade commercial operation, demonstrating progress toward deployment and securing utility offtake commitments.

Listed as a hot nuclear stock trading at higher valuations than BWX, but no performance analysis or specific commentary provided.

High-risk startup with only two potential customers but no confirmed sales; must still prove reliable manufacturing capability; suitable only for aggressive growth investors.

Pre-revenue SMR developer with one project in Romania and potential TVA deal; early-stage with significant execution risk and deployment timeline in 2030s.

Key SMR producer positioned to benefit from surging power demands from cloud infrastructure and AI markets over the next few decades.

NuScale is mentioned as a competitor facing similar challenges in SMR development. The article cites NuScale's abandonment of the Carbon Free Power Project due to cost overruns ($5.3B to $9.3B), illustrating industry-wide challenges. No direct investment recommendation or strong sentiment is expressed toward NuScale.

SMR developer offering factory-fabricated modular nuclear reactors for data center applications. High growth potential but faces long development timeline and high scaling costs.

Mentioned as competitor with different SMR design approach (water-cooled), but not directly compared or evaluated in the investment recommendation.

Only U.S. company currently approved by regulators to build SMR facilities, developing significant projects in Romania and the U.S., and has established partnerships with major utilities.

Small modular nuclear reactor provider with approved design; positioned for long-term growth as SMRs could power AI data centers, though currently money-losing startup.

Highlighted as a pioneer in small modular reactor development with strong growth potential driven by AI data center power demands, holding 4.5% weighting in the recommended ETF.

Mentioned as the company whose stake Fluor liquidated for $1.86 billion profit. No direct investment recommendation provided.

Only U.S. company with regulatory approval for SMRs, strong customer pipeline, $3 billion market cap relative to $10 trillion opportunity, and expected major project update by year-end. However, sentiment is tempered by execution risks, substantial operating losses ($690M), and past project delays.

Added for nuclear energy exposure, indicating broker recognition of nuclear's role in AI power infrastructure

Listed as one of three racing companies with significant opportunity, and The Motley Fool recommends it. However, stock declined 4.98% and was notably excluded from the Trump Administration's 'Project Prometheus' initiative, suggesting mixed prospects.

Emerging small modular reactor technology company with recent regulatory approvals and partnerships (Romania, Tennessee Valley Authority). Highest growth potential but carries startup risk and current losses.